Celcuity (CELC) News Today → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free CELC Stock Alerts $17.24 +0.85 (+5.19%) (As of 04/19/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineShort Interest in Celcuity Inc. (NASDAQ:CELC) Drops By 7.5%marketbeat.com - April 16 at 5:16 PMCelcuity (NASDAQ:CELC) Stock Rating Reaffirmed by Needham & Company LLCamericanbankingnews.com - April 14 at 4:38 AMCelcuity (NASDAQ:CELC) Given Buy Rating at Needham & Company LLCmarketbeat.com - April 12 at 8:24 AMCelcuity (NASDAQ:CELC) Stock Price Down 3.6%marketbeat.com - April 8 at 1:46 PMCelcuity (NASDAQ:CELC) Shares Up 4.5%marketbeat.com - April 4 at 2:25 PMCelcuity To Present at Upcoming Needham and Stifel Investor Conferencesglobenewswire.com - April 4 at 7:05 AMCelcuity (NASDAQ:CELC): A Biotech with Blockbuster Potentialmsn.com - April 3 at 8:22 AMCelcuity Gains 12%, Insider Trades Reap Benefitfinance.yahoo.com - April 3 at 8:22 AMCelcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - April 1 at 3:39 PMI Gave Birth At A US Hospital In 2023 — Let's Break Down My $65,000 Billmsn.com - March 30 at 3:29 PMOne dead, another in ICU after drug overdosemsn.com - March 30 at 3:29 PMGedatolisib’s Promising Clinical Trial Performance and Market Potential Justify Buy Ratingmarkets.businessinsider.com - March 29 at 4:25 PMCelcuity (NASDAQ:CELC) Price Target Raised to $25.00marketbeat.com - March 28 at 2:35 PMCelcuity (NASDAQ:CELC) Reaches New 1-Year High After Analyst Upgrademarketbeat.com - March 28 at 12:36 PMAnalysts Are Bullish on These Healthcare Stocks: Celcuity (CELC), Cara Therapeutics (CARA)markets.businessinsider.com - March 28 at 10:37 AMQ4 2023 Celcuity Inc Earnings Callfinance.yahoo.com - March 28 at 10:37 AMCelcuity's (CELC) "Buy" Rating Reiterated at HC Wainwrightmarketbeat.com - March 28 at 8:28 AMCelcuity Inc (CELC) Reports Full Year 2023 Financial Results and Highlights Key Developmentsfinance.yahoo.com - March 27 at 10:51 PMRecap: Celcuity Q4 Earningsbenzinga.com - March 27 at 5:51 PMCelcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - March 27 at 4:01 PMCelcuity (CELC) Scheduled to Post Quarterly Earnings on Thursdaymarketbeat.com - March 20 at 7:46 AMCelcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Callglobenewswire.com - March 20 at 7:05 AMCelcuity Inc. (NASDAQ:CELC) Sees Significant Growth in Short Interestmarketbeat.com - March 16 at 5:15 PMCELC Apr 2024 20.000 callfinance.yahoo.com - March 15 at 2:49 AMCelcuity to Participate in Leerink Partners Global Biopharma Conference 2024globenewswire.com - March 6 at 7:05 AMCelcuity to Participate in Cowen’s 44th Annual Health Care Conferencefinance.yahoo.com - February 28 at 11:05 AMCelcuity to Participate in Cowen's 44th Annual Health Care Conferenceglobenewswire.com - February 28 at 7:05 AMCelcuity (CELC) Price Target Increased by 12.99% to 27.95msn.com - February 25 at 9:46 AMAnalysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Celcuity (CELC)markets.businessinsider.com - February 23 at 5:59 PMStifel Initiates Coverage of Celcuity (CELC) with Buy Recommendationmsn.com - February 23 at 2:57 AMStifel starts Celcuity at buy, sees gedatolisib as potential blockbustermsn.com - February 22 at 9:56 PMCelcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancerfinance.yahoo.com - February 22 at 9:56 PMCelcuity Inc.: Celcuity Appoints Eldon Mayer as Chief Commercial Officerfinanznachrichten.de - February 20 at 8:47 AMCelcuity Appoints Eldon Mayer as Chief Commercial Officerfinance.yahoo.com - February 20 at 8:47 AMCelcuity Appoints Eldon Mayer as Chief Commercial Officerglobenewswire.com - February 20 at 7:05 AMCelcuity Inc. (NASDAQ:CELC) Sees Large Increase in Short Interestmarketbeat.com - January 28 at 9:40 AMCelcuity Inc. (NASDAQ:CELC) has caught the attention of institutional investors who hold a sizeable 33% stakefinance.yahoo.com - January 22 at 10:13 AMCelcuity (NASDAQ: CELC)fool.com - January 11 at 7:56 AMCelcuity Inc. (NASDAQ:CELC) Short Interest Up 27.8% in Decembermarketbeat.com - December 31 at 3:09 PMHC Wainwright & Co. Initiates Coverage of Celcuity (CELC) with Buy Recommendationnasdaq.com - December 9 at 12:09 AMCelcuity Stock (NASDAQ:CELC), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 8 at 7:09 PMCelcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposiumfinance.yahoo.com - December 6 at 8:45 AMCelcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposiumfinance.yahoo.com - December 1 at 3:23 PMCelcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conferencefinance.yahoo.com - November 22 at 8:45 AMCelcuity Inc. (NASDAQ:CELC) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 14 at 2:59 PMQ3 2023 Celcuity Inc Earnings Callfinance.yahoo.com - November 13 at 11:45 PMCelcuity Inc (CELC) Reports Q3 2023 Financial Results and Strategic Developmentsfinance.yahoo.com - November 13 at 1:44 PMCelcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updatesfinance.yahoo.com - November 13 at 8:44 AMCancer research company Celcuity raises $50 millionbizjournals.com - November 7 at 9:48 PMCelcuity Inc. Schedules Release of Third Quarter 2023 Financial Results and Webcast/Conference Callfinance.yahoo.com - November 6 at 9:14 AM Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address Secret Bull Market Starts in This Unusual Sector (Ad)"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. CELC Media Mentions By Week CELC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CELC News Sentiment▼0.610.52▲Average Medical News Sentiment CELC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CELC Articles This Week▼21▲CELC Articles Average Week Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Stoke Therapeutics News Today Corbus Pharmaceuticals News Today Cogent Biosciences News Today Shattuck Labs News Today Wave Life Sciences News Today Harpoon Therapeutics News Today Solid Biosciences News Today Dianthus Therapeutics News Today Gracell Biotechnologies News Today Icosavax News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CELC) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.